Leadership In Controlled Gene Expression


The Tet Technology is the most widely used technology to control gene expression as documented by:

  • More than 17,000 scientific publications as of 03/2018
  • More than 1,500 accounts at Clontech alone, serving both academic and commercial customers
  • Since 1996, more than 150 organisations have licensed the Tet Technology
    • 17 out of the top 20 pharmaceutical companies based on their netsales in 2006 are currently licensees

    IP Portfolio

    • The TET IP Portfolio comprises 14 issued patents organised in 3 patent families
    • The TET IP portfolio relates to  the original and improved versions of transcriptional activators,  silencers, responsive elements and  chromosomal loci for transgenesis
    • The Tet Technology is patent protected in North-America, Europe, Japan and Australia